• A new DIY economy

    Reinventing society will be an opportunity to create a better future, says Ian Mann.

  • Healthcare headache

    State healthcare strategies must be more than political posturing, says Mzwandile Jacks.

  • Buzzwords and truths

    Mandi Smallhorne discusses her beef with the terms 'savings' and 'entrepreneurship'.

Loading...
See More

Pfizer withdraws life-threatening drug

Dec 10 2010 16:55
AFP

New York - US pharmaceutical giant Pfizer announced on Friday it is pulling off the market its blood pressure drug Thelin due to a potentially life-threatening risk of liver injury.

Pfizer said it was voluntarily withdrawing Thelin in the European Union, Canada and Australia and is also suspending all clinical tests on the anti-hypertension drug.

"While liver toxicity is a known complication of the class of drugs to which Thelin belongs, a new potentially life-threatening idiosyncratic risk of liver injury with Thelin has been observed," Pfizer said in a statement.

"Given the availability of alternate treatments, Pfizer has concluded that the overall benefit of Thelin no longer outweighs the risk in the general population of PAH (pulmonary arterial hypertension) patients."

The company said it had notified health authorities about its findings and its decision to withdraw Thelin from the market and stop clinical studies.

pfizer  |  medicines

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
2 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

We're Talking About...

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Introducing tablets in schools is:

Previous results · Suggest a vote

Loading...